Etsuro Matsubara Selected Research

Etsuro Matsubara Research Topics

Disease

29	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 03/2002
12	Cognitive Dysfunction 01/2024 - 01/2016
10	Dementia (Dementias) 09/2023 - 09/2002
5	Tauopathies 04/2011 - 06/2006
5	Amyloidosis 08/2007 - 06/2003
4	Parkinson Disease (Parkinson's Disease) 11/2010 - 01/2002
3	Disease Progression 10/2005 - 01/2002
2	Leukocytosis (Pleocytosis) 09/2022 - 12/2021
2	Memory Disorders (Memory Loss) 01/2022 - 03/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2010 - 10/2005
2	Synucleinopathies 01/2009 - 08/2007
2	Down Syndrome (Down's Syndrome) 08/2007 - 08/2004
1	Atrial Fibrillation 03/2024
1	Cardiomyopathies (Cardiomyopathy) 03/2024
1	Wounds and Injuries (Trauma) 02/2024
1	Neurosarcoidosis 01/2023
1	Meningoencephalitis 09/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2022
1	Headache (Headaches) 09/2022
1	Neoplasms (Cancer) 09/2022
1	Amyloid Plaque 01/2022
1	Optic Neuritis (Retrobulbar Neuritis) 12/2021
1	Neurologic Manifestations (Neurological Manifestations) 12/2021
1	Muscle Rigidity 12/2021
1	Nausea 12/2021
1	Fever (Fevers) 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 12/2021
1	Pontocerebellar Hypoplasia 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Inflammation (Inflammations) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019
1	Adenomyosis 08/2018
1	Cerebral Infarction 08/2018
1	Anemia 08/2018
1	Hepatitis C 10/2017
1	Zika Virus Infection 10/2017
1	Communicable Diseases (Infectious Diseases) 10/2017
1	Viremia 10/2017
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2015

Drug/Important Bio-Agent (IBA)

22	Amyloid (Amyloid Fibrils)IBA 03/2024 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2002
7	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
5	Amyloid beta-PeptidesIBA 07/2010 - 06/2003
4	Presenilin-1IBA 08/2007 - 03/2002
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 02/2024 - 11/2017
3	AntibodiesIBA 01/2023 - 06/2008
2	Prealbumin (Transthyretin)IBA 03/2024 - 01/2009
2	CytokinesIBA 01/2024 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 09/2022 - 12/2021
2	PresenilinsIBA 01/2022 - 05/2005
2	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 06/2003
2	Prion ProteinsIBA 01/2015 - 02/2005
2	MelatoninIBA 02/2012 - 06/2003
2	Lipoproteins (Lipoprotein)IBA 06/2011 - 08/2004
2	alpha-SynucleinIBA 01/2009 - 08/2007
2	Dopamine (Intropin)FDA LinkGeneric 09/2004 - 01/2002
1	B-Cell Activating FactorIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 09/2022
1	IpilimumabIBA 09/2022
1	NivolumabIBA 09/2022
1	Thyroid HormonesIBA 05/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2021
1	GadoliniumIBA 12/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021
1	SteroidsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	Transfer RNA (tRNA)IBA 01/2020
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2020
1	AdiponectinIBA 01/2020
1	flotillinsIBA 01/2019
1	fibrin fragment D (D-dimer)IBA 08/2018
1	RivaroxabanIBA 08/2018
1	Heparin (Liquaemin)FDA LinkGeneric 08/2018
1	Tumor Biomarkers (Tumor Markers)IBA 08/2018
1	AnticoagulantsIBA 08/2018
1	Threonine (L-Threonine)FDA Link 11/2017
1	Ribavirin (Virazole)FDA LinkGeneric 10/2017
1	Antiviral Agents (Antivirals)IBA 10/2017
1	InterferonsIBA 10/2017
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2017
1	Viral RNAIBA 10/2017
1	Yi-Gan SanIBA 02/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	human MIRN191 microRNAIBA 01/2016
1	Codon (Codons)IBA 01/2015
1	LithiumIBA 01/2015
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2015
1	indoleIBA 02/2012

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2002
2	Immunotherapy 02/2012 - 07/2010
1	Hysterectomy 08/2018
1	Secondary Prevention 01/2016